Literature DB >> 3231410

Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients.

W E Benson1, G C Brown, W Tasman, J A McNamara.   

Abstract

One hundred consecutive patients with proliferative diabetic retinopathy underwent vitrectomy for nonclearing vitreous hemorrhage. Eighty-two had significantly improved vision; nine had no improvement in vision; and nine had complications which resulted in permanent loss of vision. Only three eyes lost vision because of neovascular glaucoma. Our results indicate that with improved surgical techniques, the incidence of vitrectomy complications is decreasing.

Entities:  

Mesh:

Year:  1988        PMID: 3231410

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment.

Authors:  J Fernando Arevalo; Martin A Serrano; Juan D Arias
Journal:  World J Diabetes       Date:  2014-10-15

Review 2.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

3.  Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.

Authors:  M A Kotterman; L Yin; J M Strazzeri; J G Flannery; W H Merigan; D V Schaffer
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

4.  Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.

Authors:  Morteza Entezari; Alireza Ramezani; Hamid Ahmadieh; Pejman Bakhtiari; Mehdi Yaseri; Kian Soltani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

Review 5.  Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Authors:  Jonathan M Smith; David H W Steel
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.